RecruitingPhase 2NCT07539792
Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled Study
Studying Isolated femoral agenesis/hypoplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Nanfang Hospital, Southern Medical University
- Intervention
- Absorbable and moldable skull base support plate(device)
- Enrollment
- 126 target
- Eligibility
- 1-80 years · All sexes
- Timeline
- 2026 – 2030
Study locations (8)
- The First People's Hospital Of Foshan, Foshan, Guangdong, China
- Gaozhou People's Hospital, Gaozhou, Guangdong, China
- Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
- Southern Medical University, Nanfang Hospital, Department of Neurosurgery, Guangzhou, Guangdong, China
- Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China
- Huizhou Central People's Hospital, Huizhou, Guangdong, China
- The First People's Hospital of Zhaoqing, Zhaoqing, Guangdong, China
- Liuzhou people's hospital, Liuzhou, Guangxi, China
Collaborators
First People's Hospital of Zhaoqing · Sun Yat-Sen University Cancer Center · Guangdong Provincial Hospital of Traditional Chinese Medicine · The People's Hospital of Gaozhou · First People's Hospital of Foshan · Huizhou Municipal Central Hospital · LiuZhou People's Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07539792 on ClinicalTrials.govOther trials for Isolated femoral agenesis/hypoplasia
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07151794G8, CARG, Frailty, and Nutritional Markers in Predicting ChemotoxicityÇanakkale Onsekiz Mart University
- RECRUITINGEARLY PHASE1NCT06216938RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node MetastasisYana Najjar
- RECRUITINGNCT06164483Auditory Functions in Patients With Multiple SclerosisUniversity of Catania
- RECRUITINGPHASE2NCT05817214Cadonilimab Plus Anlotinib for R/M/P Cervical CancerZhongnan Hospital
- ENROLLING BY INVITATIONNANCT04498026Adherus™ Dural Sealant in Spinal ProceduresStryker Craniomaxillofacial
- RECRUITINGNANCT04099823MR Evaluation of Cerebrospinal Fluid (CSF) DynamicsMayo Clinic
- RECRUITINGPHASE1, PHASE2NCT03866525OH2 Oncolytic Viral Therapy in Solid TumorsBinhui Biopharmaceutical Co., Ltd.
- RECRUITINGPHASE1, PHASE2NCT04386967OH2 Injection in Solid TumorsBinhui Biopharmaceutical Co., Ltd.